Tech Company Financing Transactions

HiFiBiO Therapeutics Funding Round

HiFiBiO Therapeutics, operating out of Cambridge, secured $67 million from IDG Capital Partners, Delian Capital and Hanne Capital.

Transaction Overview

Announced On
8/29/2019
Transaction Type
Venture Equity
Amount
$67,000,000
Round
Series C
Proceeds Purpose
HiFiBiO Therapeutics will use the proceeds from the financing to expand its platform efforts and accelerate the development of its novel antibody drug pipeline to treat cancer and autoimmune disorders.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
237 Putnam Ave.
Cambridge, MA 02139
USA
Phone
Undisclosed
Email Address
Overview
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease.
Profile
HiFiBiO Therapeutics LinkedIn Company Profile
Social Media
HiFiBiO Therapeutics Company Twitter Account
Company News
HiFiBiO Therapeutics News
Facebook
HiFiBiO Therapeutics on Facebook
YouTube
HiFiBiO Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Liang Schweizer
  Liang Schweizer LinkedIn Profile  Liang Schweizer Twitter Account  Liang Schweizer News  Liang Schweizer on Facebook
Chief Financial Officer
Fred Dom
  Fred Dom LinkedIn Profile  Fred Dom Twitter Account  Fred Dom News  Fred Dom on Facebook
Chief Financial Officer
Philip Sin
  Philip Sin LinkedIn Profile  Philip Sin Twitter Account  Philip Sin News  Philip Sin on Facebook
Chief Operating Officer
Jeffrey He
  Jeffrey He LinkedIn Profile  Jeffrey He Twitter Account  Jeffrey He News  Jeffrey He on Facebook
Vice President
Luigi Manenti
  Luigi Manenti LinkedIn Profile  Luigi Manenti Twitter Account  Luigi Manenti News  Luigi Manenti on Facebook
VP - Administration
Vincent Tse
  Vincent Tse LinkedIn Profile  Vincent Tse Twitter Account  Vincent Tse News  Vincent Tse on Facebook
VP - General Counsel
Xuqiong Wu
  Xuqiong Wu LinkedIn Profile  Xuqiong Wu Twitter Account  Xuqiong Wu News  Xuqiong Wu on Facebook
VP - R & D
Francisco Adrian
  Francisco Adrian LinkedIn Profile  Francisco Adrian Twitter Account  Francisco Adrian News  Francisco Adrian on Facebook
VP - R & D
Nicola Beltraminelli
  Nicola Beltraminelli LinkedIn Profile  Nicola Beltraminelli Twitter Account  Nicola Beltraminelli News  Nicola Beltraminelli on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/29/2019: Apollo Endosurgery venture capital transaction
Next: 8/29/2019: VRChat venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary